You are here:

  1. Home
  2. NICE Guidance
  3. Conditions and diseases
  4. Infections
  5. Healthcare-associated infections

Reducing the risk of transmission of Creutzfeldt–Jakob disease (CJD) from surgical instruments used for interventional procedures on high-risk tissues

  • Interventional procedures guidance
  • Reference number: IPG666
  • Published:  22 January 2020

Register an interest

  • Guidance
  • Tools and resources
  • Information for the public
  • Evidence
  • History
Download guidance (PDF)
  • Overview
  • This guidance is for high-risk tissues
  • 1 Recommendations
  • 2 Indication
  • 3 Committee considerations
  • 4 Committee comments
  • Appendix A: Creutzfeldt–Jakob disease advisory subcommittee members and NICE project team
  • Appendix B: Contributors
  • Appendix C: Related advisory groups
  • Appendix D: High-risk procedures

Appendix C: Related advisory groups

A number of advisory committees, expert groups and academic units are addressing issues related to Creutzfeldt–Jakob disease (CJD) including developing the scientific basis of our understanding of the disease, improving decontamination practices across the NHS and minimising the risk of transmission. NICE has made every effort to coordinate with these groups to ensure that this guidance takes account of, and builds on, their work. Some members of the CJD advisory subcommittee are also members of other CJD committees, working groups and academic units. NICE has been represented on some of these groups.

The following is a list of some of the organisations in the UK that either fund surveillance, study or provide advice on the public health aspect of CJD:

  • Department of Health and Social Care

  • Medical Research Council Prion Unit at University College London Hospitals' National Prion Clinic

  • University of Edinburgh National CJD Research & Surveillance Unit

  • Public Health England

  • Health Protection Scotland


Next page Appendix D: High-risk procedures Previous page Appendix B: Contributors
Back to top